New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Citius Pharmaceuticals, Inc.
CTXR
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

66M

Biotechnology

Next Earning date - 27 Dec 2024

66M

Biotechnology

Next Earning date - 27 Dec 2024

0.37USD
Shape-0.03 ( -8.22%)
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

-35%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

66%

Quote Panel

Shape
Updated October 12, 2024
1W -7.04 % 1M -29.37 % 3M -52.02 % 1Y -47.39 %

Key Metrics

Shape
  • Market Cap

    66.36M


  • Shares Outstanding

    180.73M


  • Share in Float

    168.40M


  • Dividende

    0


  • Earning Date

    27 Dec 2024


  • Price Target

    0.3672


  • Average Volume

    1.66M


  • Beta

    1.611


  • Range

    0.3672-1.07


  • Industry

    Biotechnology


  • Website

    https://www.citiuspharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.75x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-0.2

EPS

How CTXR compares to sector?

P/E Ratio

Relative Strength

Shape

CTXR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$86M

ShapeNaN%

2025-Revenue

$0.07

Shape210%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

EF Hutton

initialise

Previous: Not converted

2024-07-15

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.05
vs -0.03

Q4.22

arrow
arrow

N/A

-0.04
vs -0.06

Q1.23

arrow
arrow

N/A

-0.07
vs -0.05

Q2.23

arrow
arrow

N/A

-0.06
vs -0.06

Q3.23

arrow
arrow

N/A

-0.07
vs -0.05

Q4.23

arrow
arrow

N/A

-0.06
vs -0.04

Q1.24

arrow
arrow

N/A

-0.05
vs -0.07

Q2.24

arrow
arrow

N/A

-0.06
vs -0.06

Q3.24

arrow
arrow

N/A

-0.05
vs -0.07

Q4.24

arrow
arrow

+167%

0.04
vs -0.06

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

17.3M  vs NA

Q4.24

arrow
arrow

NA

21.2M  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.08

Q4.22

arrow
arrow

-4%

-0.04
vs -0.08

Q1.23

arrow
arrow

-12%

-0.12
vs -0.04

Q2.23

arrow
arrow

-9%

-0.09
vs -0.12

Q3.23

arrow
arrow

-11%

-0.11
vs -0.09

Q4.23

arrow
arrow

-11%

-0.11
vs -0.11

Q1.24

arrow
arrow

-11%

-0.11
vs -0.11

Q2.24

arrow
arrow

-12%

-0.12
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

56

56
vs 57

-2%

Q4.22

arrow
arrow

55

55
vs 56

-2%

Q1.23

arrow
arrow

59

59
vs 55

7%

Q2.23

arrow
arrow

78

78
vs 59

32%

Q3.23

arrow
arrow

76

76
vs 78

-3%

Q4.23

arrow
arrow

75

75
vs 76

-1%

Q1.24

arrow
arrow

72

72
vs 75

-4%

Q2.24

arrow
arrow

70

70
vs 72

-3%

Earnings Growth

Latest News